Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Aug 9, 2017View HTMLDownload DOCDownload PDFDownload XLS
424B5Form of prospectus disclosing information facts events covered in both forms 424B2 424B3Aug 8, 2017View HTMLDownload DOCDownload PDFDownload XLS
S-8 POSPost-effective amendment to an S-8 filingJun 13, 2017View HTMLDownload DOCDownload PDFDownload XLS
S-8 POSPost-effective amendment to an S-8 filingJun 13, 2017View HTMLDownload DOCDownload PDFDownload XLS
S-8 POSPost-effective amendment to an S-8 filingJun 13, 2017View HTMLDownload DOCDownload PDFDownload XLS
S-8Securities offered to employees pursuant to employee benefit plansJun 13, 2017View HTMLDownload DOCDownload PDFDownload XLS
S-8 POSPost-effective amendment to an S-8 filingJun 13, 2017View HTMLDownload DOCDownload PDFDownload XLS

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information